About Salmobreed
Salmobreed is a Healthcare company based in Bergen (Norway) founded in 1999, and was acquired by Benchmark Holdings in November 2014. Breeding technology research and supply of Atlantic salmon eggs. It operates in the Healthcare and Agriculture sectors. The company has 837 employees. The company was acqui-hired. Salmobreed offers products and services including Salmon Ova, Shrimp Genetics, and Genetic Services. Its focus areas include Food and Agriculture Tech, Aquaculture Tech, Genetic Breeding and Eggs. Its legal entity is BENCHMARK GENETICS NORWAY AS.
Company details
SalmonBreed is a biotechnology company involved in breeding technology research and supply of Atlantic salmon eggs. It uses genomic research and long-term breeding programs while using various genetic traits to develop eggs of hybrid varieties. The product portfolio has eggs from Salmobreed tribe, Icelandic roe, customized strains by combining both the varieties, organic salmon eggs, triploid roe sterile fish for avoiding inbreed from wild salmon stock, all female stock for avoiding losses from the male fish stock in the early stages, and land-based farming fish for late maturation. It also provides crossbreed variety by combining traits developed by its sister company Stofnfiskur.
- Headquarters Bergen, Norway
- Employees 837
- Stage Acquired
- SectorsHealthcareAgriculture
- Email••••••••
- Website salmobreed.no
- Social LinkedIn X Facebook
- Acquired by Benchmark Holdings (Nov 2014)
- Legal Name Benchmark Genetics Norway As
- Annual Revenue$37.16 M (USD)22as on Dec 31, 2022
- Net Profit$3.35 M (USD)106as on Dec 31, 2022
- EBITDA$3.93 M (USD)121as on Dec 31, 2022
- Investors
- Employee Count837
- Acquired byBenchmark Holdings
(Nov 2014)
Products & Services of Salmobreed
Salmobreed offers a comprehensive portfolio of products and services, including Salmon Ova, Shrimp Genetics, and Genetic Services.
Breeding ova for salmon to improve growth and disease resistance.
Genetic solutions for enhancing shrimp aquaculture sustainability.
Provides genotyping and breeding support for global aquaculture.
Investors in Salmobreed
Salmobreed has secured backing from 1 investor. Prominent investors backing the company include Benchmark Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Advanced nutrition and health solutions for aquaculture are provided. | 2000 | benchmarkplc.com | Sheffield, United Kingdom |
Investor details for Salmobreed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Salmobreed
2 dated milestones of Salmobreed across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Salmobreed is founded.
- Exit Acquired by Benchmark Holdings.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Salmobreed
Salmobreed was founded in 1999.
Salmobreed is headquartered in Bergen, Norway. It is registered at Bergen, Vestland, Norway.
Salmobreed has 837 employees.
Annual revenue of Salmobreed is $37.16M as on Dec 31, 2022.
SalmonBreed is a biotechnology company involved in breeding technology research and supply of Atlantic salmon eggs. It uses genomic research and long-term breeding programs while using various genetic traits to develop eggs of hybrid varieties. The product portfolio has eggs from Salmobreed tribe, Icelandic roe, customized strains by combining both the varieties, organic salmon eggs, triploid roe sterile fish for avoiding inbreed from wild salmon stock, all female stock for avoiding losses from the male fish stock in the early stages, and land-based farming fish for late maturation. It also provides crossbreed variety by combining traits developed by its sister company Stofnfiskur.
Salmobreed offers Salmon Ova, Shrimp Genetics, and Genetic Services.
Salmobreed has 1 investor. Key investors include Benchmark Holdings.
Salmobreed operates through Benchmark Genetics Norway As.
Yes. Salmobreed was acquired by Benchmark Holdings in November 2014.